The potential to regenerate women’s eggs is the latest breakthrough in reproductive research. But there are risks to perturbing nature.
Many problems with therapies show up post-FDA approval. Could mining electronic data and online chatter head off trouble?
Issues of privacy and consent are scarcely slowing the race to build enormous, invaluable “biobanks” of human tissue and data.
There’s ample proof that physician empathy can benefit doctors as well as patients. Next challenge: teaching medicine’s softer side.
Peter L. Slavin and David F. Torchiana discuss the Boston Marathon bombings and empathic care.
Proto readers share their thoughts on veterinary medicine, medical journals and hospital mergers.
By collecting DNA from public places, the artist can create 3-D portraits. Here’s a slideshow of her work.
Nobel Prize-winning economist Kenneth Arrow discusses the current state of the health care industry.
UV light proves itself as an annihilator of germs.
New York City’s medical research community picks up the pieces after Hurricane Sandy destroys decades of work.
With his creation of the American College of Surgeons 100 years ago, Franklin Martin introduced a vital aspect to surgery: regulation.
Physicians routinely prescribe drugs for uses not approved by the FDA. But should drug reps be allowed to tout those uses?
Although drug shortages have lessened in recent years, some key classes of medications remain in short supply.
One group wishes to manage a surgical patient’s entire course of care: anesthesiologists.
Against all odds, a husband stands by his wife to beat the ultimate battle: cancer.